23,125,000 Ordinary Shares of Cengild Medical Berhad are subject to a Lock-Up Agreement Ending on 18-OCT-2022. These Ordinary Shares will be under lockup for 193 days starting from 8-APR-2022 to 18-OCT-2022.

Details:
The moratorium applies to the entire shareholdings of our Promoters for a period of 6 months from the date of our admission to the ACE Market (“First 6-Month Moratorium”).

Upon the expiry of the First 6-Month Moratorium, our Company must ensure that our Promoters' aggregate shareholdings amounting to at least 45% of our nominal ordinary share capital remain under moratorium for another period of 6 months (“Second 6-Month Moratorium”).

On the expiry of the Second 6-Month Moratorium, our Promoters may sell, transfer or assign up to a maximum of 1/3 per annum (on a straight line basis) of those Cengild Medical Shares held under moratorium.